Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Agilent Opens Spectroscopy Technology Center | Contract Pharma

What are you searching for?

Sign in
Breaking News

Agilent Opens Spectroscopy Technology Center

Invests in research and testing labs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Agilent Technologies has opened its Spectroscopy Technology Innovation Center in Mulgrave, Australia. The company has invested $25 million in research and testing laboratories, as well as customer demo and training facilities.
 
Spectroscopy instruments such as Agilent’s atomic absorption spectrometer are critical measurement tools in a variety of applications in the food, environmental and pharmaceutical markets, measuring for quality and containments. The facility, located within the Monash Technology Precinct, provides communications technology to facilitate collaboration between Agilent divisions, research partners and customers globally.
 
“The Spectroscopy Technology Innovation Center is Agilent’s next big leap in developing world-leading spectroscopy products,” said Mike McMullen, president of Agilent’s Chemical Analysis Group. “The open-plan areas for project teams have been designed to foster interaction and to help improve customer and field linkages. Most importantly, our time-to-market for new products will be improved as we pursue our goal of clear leadership in our chosen markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters